CD4 and liver cancer: However, although PD-1 inhibitors can significantly block PD-1 receptors on the surface of T cells, we established that neither the baseline levels of CD8+PD-1+ and CD4+PD-1+ T cells nor the ratio or changes in these cells would serve as effective predictors of the prognosis of patients with liver cancer.